{
  "domain": "Clinical Development",
  "use_case": {
    "code": "UC_CD_001",
    "title": "DTx Clinical Endpoint Selection & Validation",
    "summary": "Systematic process for selecting and validating clinical endpoints for digital therapeutics trials, ensuring regulatory acceptability, clinical meaningfulness, and patient-centered design.",
    "complexity": "Expert",
    "workflows": [
      {
        "name": "Endpoint Selection & Validation Workflow",
        "description": "End-to-end workflow guiding teams through context definition, precedent research, endpoint identification, validation, and final regulatory alignment.",
        "tasks": [
          {
            "code": "T1.1",
            "title": "Define Clinical Context",
            "objective": "Establish a shared understanding of the clinical problem, mechanism of action, and target population.",
            "agents": ["P01_CMO", "P10_PATADV"],
            "tools": ["Literature DB", "Clinical Context Template"],
            "dependencies": [],
            "inputs": ["DTx Product Description", "Indication Summary"],
            "outputs": ["Clinical Context Document"],
            "prompts": [
              {
                "name": "Clinical_Context_Definition",
                "pattern": "CoT",
                "system_prompt": "You are a Chief Medical Officer defining the clinical context for a new digital therapeutic.",
                "user_template": "Describe the clinical problem, target population, mechanism of action, and unmet need for {product_name} in {indication}. Include standard of care and patient impact."
              }
            ],
            "kpis": {
              "Completeness (%)": 100,
              "Stakeholder Alignment (%)": 90
            }
          },
          {
            "code": "T1.2",
            "title": "Identify Patient-Centered Outcomes",
            "objective": "Capture and prioritize outcomes that matter most to patients to inform endpoint design.",
            "agents": ["P10_PATADV", "P01_CMO"],
            "tools": ["Patient Interview Guide", "Outcome Prioritization Matrix"],
            "dependencies": ["T1.1"],
            "inputs": ["Clinical Context Document"],
            "outputs": ["Patient-Centered Outcomes Report"],
            "prompts": [
              {
                "name": "Patient_Outcome_Prioritization",
                "pattern": "Few-Shot",
                "system_prompt": "You are a Patient Advocate summarizing what outcomes matter most to patients with this condition.",
                "user_template": "List and rank the top 5 patient outcomes for {target_condition}. Include why they matter, how they are experienced, and potential measurement methods."
              }
            ],
            "kpis": {
              "Patient Participation Rate (%)": 80,
              "Outcome Alignment Score": 4.5
            }
          },
          {
            "code": "T2.1",
            "title": "Research Regulatory Precedent",
            "objective": "Identify and analyze FDA-cleared endpoints used in similar DTx indications.",
            "agents": ["P02_VPCLIN", "P05_REGDIR"],
            "tools": ["FDA De Novo Database", "Internal Regulatory Archive"],
            "dependencies": ["T1.2"],
            "inputs": ["Clinical Context Document", "Patient-Centered Outcomes Report"],
            "outputs": ["Regulatory Precedent Analysis"],
            "prompts": [
              {
                "name": "DTx_Precedent_Analysis",
                "pattern": "RAG",
                "system_prompt": "You are a VP Clinical Development expert at analyzing FDA precedent.",
                "user_template": "Search FDA databases for DTx with similar {indication} or {mechanism}. Summarize their primary endpoints, instruments, comparators, and acceptance status."
              }
            ],
            "kpis": {
              "Number of Precedents Found": 5,
              "Analysis Quality Score": 4.8
            }
          },
          {
            "code": "T2.2",
            "title": "Review FDA Guidance",
            "objective": "Summarize key regulatory expectations for endpoint validation and documentation.",
            "agents": ["P05_REGDIR"],
            "tools": ["FDA Guidance Library"],
            "dependencies": ["T2.1"],
            "inputs": ["Regulatory Precedent Analysis"],
            "outputs": ["FDA Guidance Summary"],
            "prompts": [
              {
                "name": "FDA_Guidance_Review",
                "pattern": "RAG",
                "system_prompt": "You are a Regulatory Affairs Director extracting key points from FDA endpoint guidance.",
                "user_template": "Summarize endpoint selection principles, validation requirements, and risk mitigation from relevant FDA guidance documents for {indication}."
              }
            ],
            "kpis": {
              "Guidance Coverage (%)": 100
            }
          },
          {
            "code": "T3.1",
            "title": "Identify Primary Endpoint Candidates",
            "objective": "Generate and evaluate strong primary endpoint candidates based on precedent and feasibility.",
            "agents": ["P01_CMO", "P04_BIOSTAT"],
            "tools": ["Endpoint Evaluation Template"],
            "dependencies": ["T2.2"],
            "inputs": ["FDA Guidance Summary", "Patient-Centered Outcomes Report"],
            "outputs": ["Primary Endpoint Candidate Analysis"],
            "prompts": [
              {
                "name": "Primary_Endpoint_Identification",
                "pattern": "CoT",
                "system_prompt": "You are a CMO selecting primary endpoints for a DTx clinical trial.",
                "user_template": "List and evaluate possible endpoints for {indication}, scoring each for regulatory precedent, clinical meaningfulness, psychometric strength, and patient burden."
              }
            ],
            "kpis": {
              "Number of Candidates": 3,
              "Feasibility Score": 4.2
            }
          },
          {
            "code": "T3.2",
            "title": "Develop Secondary Endpoint Package",
            "objective": "Select secondary endpoints to support regulatory and commercial goals.",
            "agents": ["P01_CMO", "P02_VPCLIN"],
            "tools": ["Commercial Value Matrix"],
            "dependencies": ["T3.1"],
            "inputs": ["Primary Endpoint Candidate Analysis"],
            "outputs": ["Secondary Endpoint Strategy"],
            "prompts": [
              {
                "name": "Secondary_Endpoint_Package",
                "pattern": "Few-Shot",
                "system_prompt": "You are a Clinical Strategist creating a balanced secondary endpoint package.",
                "user_template": "Based on {primary_endpoints}, recommend 3–5 secondary endpoints supporting commercial and regulatory claims. Include purpose and measurement frequency."
              }
            ],
            "kpis": {
              "Endpoint Diversity Index": 0.8
            }
          },
          {
            "code": "T4.1",
            "title": "Assess Psychometric Properties",
            "objective": "Evaluate reliability, validity, and responsiveness for each candidate endpoint.",
            "agents": ["P04_BIOSTAT"],
            "tools": ["PubMed", "Psychometric Database"],
            "dependencies": ["T3.2"],
            "inputs": ["Primary Endpoint Candidate Analysis"],
            "outputs": ["Psychometric Assessment Report"],
            "prompts": [
              {
                "name": "Psychometric_Evaluation",
                "pattern": "CoT",
                "system_prompt": "You are a biostatistician evaluating psychometric properties.",
                "user_template": "For each {endpoint}, summarize reliability (α), validity (construct, criterion), responsiveness, and MCID. Rate overall psychometric strength (1-5)."
              }
            ],
            "kpis": {
              "Endpoints with Strong Psychometrics (%)": 80
            }
          },
          {
            "code": "T4.2",
            "title": "Evaluate Digital Feasibility",
            "objective": "Confirm digital collection feasibility, data quality, and technical burden.",
            "agents": ["P06_PMDIG"],
            "tools": ["Platform Capability Matrix"],
            "dependencies": ["T4.1"],
            "inputs": ["Psychometric Assessment Report"],
            "outputs": ["Digital Feasibility Analysis"],
            "prompts": [
              {
                "name": "Digital_Feasibility_Assessment",
                "pattern": "Few-Shot",
                "system_prompt": "You are a Product Manager assessing digital feasibility for clinical endpoints.",
                "user_template": "For each {endpoint}, assess feasibility of digital data capture, estimated development effort, and expected completion rate."
              }
            ],
            "kpis": {
              "Endpoints Rated Feasible (%)": 85
            }
          },
          {
            "code": "T4.3",
            "title": "Evaluate Patient Burden",
            "objective": "Calculate and assess patient time and cognitive burden for all assessments.",
            "agents": ["P10_PATADV", "P06_PMDIG"],
            "tools": ["Assessment Burden Calculator"],
            "dependencies": ["T4.2"],
            "inputs": ["Endpoint Candidate List", "Digital Feasibility Analysis"],
            "outputs": ["Patient Burden Report"],
            "prompts": [
              {
                "name": "Patient_Burden_Estimator",
                "pattern": "CoT",
                "system_prompt": "You are a patient advocate assessing endpoint burden.",
                "user_template": "Compute total assessment time for all {endpoints}. Identify high-burden measures (>15 min) and propose burden-reduction options."
              }
            ],
            "kpis": {
              "Average Burden (min)": 12
            }
          },
          {
            "code": "T5.1",
            "title": "Regulatory Risk Assessment",
            "objective": "Evaluate acceptance likelihood and mitigation strategies for each endpoint.",
            "agents": ["P05_REGDIR", "P01_CMO"],
            "tools": ["Regulatory Risk Matrix"],
            "dependencies": ["T4.3"],
            "inputs": ["Psychometric Assessment Report", "Patient Burden Report"],
            "outputs": ["Regulatory Risk Assessment Plan"],
            "prompts": [
              {
                "name": "Regulatory_Risk_Assessment",
                "pattern": "CoT",
                "system_prompt": "You are a Regulatory Affairs Director performing endpoint risk analysis.",
                "user_template": "For each {endpoint}, assess FDA acceptance likelihood, risks, mitigation plans, and backup strategies."
              }
            ],
            "kpis": {
              "Endpoints with Acceptable Risk (%)": 90
            }
          },
          {
            "code": "T5.2",
            "title": "Final Recommendation & Stakeholder Alignment",
            "objective": "Synthesize all evidence and finalize endpoint strategy for FDA submission.",
            "agents": ["P01_CMO", "P05_REGDIR", "P10_PATADV", "P04_BIOSTAT"],
            "tools": ["Endpoint Decision Matrix", "Executive Deck Template"],
            "dependencies": ["T5.1"],
            "inputs": ["Regulatory Risk Assessment Plan"],
            "outputs": [
              "Final Endpoint Selection Report",
              "Executive Summary",
              "Stakeholder Presentation Deck"
            ],
            "prompts": [
              {
                "name": "Decision_Matrix_Creation",
                "pattern": "CoT",
                "system_prompt": "You are a CMO finalizing endpoint recommendations.",
                "user_template": "Compare all endpoints across criteria (regulatory confidence, psychometric strength, patient burden, feasibility) and recommend primary and secondary endpoints."
              }
            ],
            "kpis": {
              "Decision Consensus (%)": 100
            }
          }
        ]
      }
    ]
  }
}

